Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier

被引：10
|
作者：
Critchley, Bethan J. [1 ]
Gaspar, H. Bobby [1 ,2 ]
Benedetti, Sara [1 ,3 ]
机构：
[1] UCL Great Ormond St Inst Child Hlth, Zayed Ctr Res, Infect Immun & Inflammat Res & Teaching Dept, London WC1N 1DZ, England
[2] Orchard Therapeut Ltd, London EC4N 6EU, England
[3] NIHR Great Ormond St Hosp Biomed Res Ctr, London, England
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 03期
关键词：
ENZYME REPLACEMENT THERAPY; STEM-CELL TRANSPLANTATION; NEURONAL CEROID-LIPOFUSCINOSIS; MUCOPOLYSACCHARIDOSIS TYPE-II; INTRACEREBROVENTRICULAR GENE-THERAPY; TRANSFERRIN RECEPTOR ANTIBODY; DELAYS NEUROLOGICAL DISEASE; PRECLINICAL MOUSE MODEL; ALPHA-L-IDURONIDASE; CANINE MODEL;
D O I：
10.1016/j.ymthe.2022.11.015
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Lysosomal storage diseases (LSDs) are multisystem inherited metabolic disorders caused by dysfunctional lysosomal activity, resulting in the accumulation of undegraded macromolecules in a variety of organs/tissues, including the central nervous sys-tem (CNS). Treatments include enzyme replacement therapy, stem/progenitor cell transplantation, and in vivo gene therapy. However, these treatments are not fully effective in treating the CNS as neither enzymes, stem cells, nor viral vectors efficiently cross the blood-brain barrier. Here, we review the latest ad-vancements in improving delivery of different therapeutic agents to the CNS and comment upon outstanding questions in the field of neurological LSDs.
引用
收藏
页码：657 / 675
页数：19
相关论文
共 50 条
  • [21] Immunologic privilege in the central nervous system and the blood-brain barrier
    Muldoon, Leslie L.
    Alvarez, Jorge I.
    Begley, David J.
    Boado, Ruben J.
    del Zoppo, Gregory J.
    Doolittle, Nancy D.
    Engelhardt, Britta
    Hallenbeck, John M.
    Lonser, Russell R.
    Ohlfest, John R.
    Prat, Alexandre
    Scarpa, Maurizio
    Smeyne, Richard J.
    Drewes, Lester R.
    Neuwelt, Edward A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2013, 33 (01): : 13 - 21
  • [22] The blood-brain barrier and drug delivery in the central nervous system
    Loch-Neckel, Gecioni
    Koepp, Janice
    REVISTA DE NEUROLOGIA, 2010, 51 (03) : 165 - 174
  • [23] Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair
    Sharma, Aruna
    Menon, Preeti
    Muresanu, Dafin F.
    Ozkizilcik, Asya
    Tian, Z. Ryan
    Lafuente, Jose V.
    Sharma, Hari S.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2016, 15 (09) : 1092 - 1117
  • [24] The "fate" of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood-brain barrier crossing and trafficking into the central nervous system
    Tosi, Giovanni
    Musumeci, Teresa
    Ruozi, Barbara
    Carbone, Claudia
    Belletti, Daniela
    Pignatello, Rosario
    Vandelli, Maria Angela
    Puglisi, Giovanni
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2016, 32 : 66 - 76
  • [25] MicroRNAs in central nervous system diseases: A prospective role in regulating blood-brain barrier integrity
    Ma, Feifei
    Zhang, Xuejing
    Yin, Ke-Jie
    EXPERIMENTAL NEUROLOGY, 2020, 323
  • [26] Extracellular Vesicles as Tools for Crossing the Blood-Brain Barrier to Treat Lysosomal Storage Diseases
    Lerussi, Giovanni
    Villagrasa-Araya, Veronica
    Molto-Abad, Marc
    del Toro, Mireia
    Pintos-Morell, Guillem
    Seras-Franzoso, Joaquin
    Abasolo, Ibane
    LIFE-BASEL, 2025, 15 (01):
  • [27] Modifying blood-brain barrier transport to bring hope for patients with lysosomal storage diseases
    Keep, Richard F.
    Xiang, Jianming
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 (03): : 474 - 475
  • [28] A new approach to deliver drugs across the blood-brain barrier
    de Boer, A. G.
    Gaillard, P. J.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 : A94 - A95
  • [29] Role of efflux transport across the blood-brain barrier and blood cerebrospinal fluid barrier on the disposition of xenobiotics in the central nervous system
    Suzuki, H
    Terasaki, T
    Sugiyama, Y
    ADVANCED DRUG DELIVERY REVIEWS, 1997, 25 (2-3) : 257 - 285
  • [30] The blood-brain barrier: A central role in the pathology and treatment of neuronopathic lysosomal storage disorders
    Begley, David
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) : S10 - S10
12345